Case Report: Safety and Efficacy of Denosumab in Four Children With Noonan Syndrome With Multiple Giant Cell Lesions of the Jaw

Cherubism: a systematic literature review of clinical and molecular aspects

(2020) B.R. Chrcanovic et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib

(2019) Pat Ricalde et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern

(2019) Anna M. Stagner et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Clinical factors associated with the recurrence of central giant cell lesions

(2019) Bruno Ramos Chrcanovic et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study

(2018) Marius Bredell et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Central giant cell lesion of the jaws: An updated analysis of 2270 cases reported in the literature

(2018) Bruno Ramos Chrcanovic et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone

(2017) Suma Uday et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Severe hypercalcemia following denosumab treatment in a juvenile patient

(2015) Nokitaka Setsu et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

(2015) Nathan Gossai et al.   PEDIATRIC BLOOD & CANCER

Management of Central Giant Cell Granuloma With Subcutaneous Denosumab Therapy

(2014) Aparna Naidu et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Effects of RANK-Ligand Antibody (Denosumab) Treatment on Bone Turnover Markers in a Girl With Juvenile Paget's Disease

(2013) Corinna Grasemann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

(2013) Sant Chawla et al.   LANCET ONCOLOGY

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

(2012) D. G. Branstetter et al.   CLINICAL CANCER RESEARCH

Denosumab treatment for fibrous dysplasia

(2012) Alison M Boyce et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Noonan-like/multiple giant cell lesion syndrome in two adult patients with SOS1 gene mutations

(2010) Ryszard Slezak et al.   CLINICAL DYSMORPHOLOGY

SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions

(2009) Claire Beneteau et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome

(2008) Thomas E Neumann et al.   EUROPEAN JOURNAL OF HUMAN GENETICS